China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)
NCT05221580
·
clinicaltrials.gov ↗
COMPLETED
Status
887
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Ryzodeg®
Sponsor
Novo Nordisk A/S